Denmark vs Germany: Reported rate of new cervical cancer cases
Denmark
8.87 per 100,000 women
in 2022
Germany
7.49 per 100,000 women
in 2017
Denmark rank
21st
Germany rank
24th
Reported rate of new cervical cancer cases over time
- Denmark
- Germany
How they compare
Denmark currently reports 8.87 per 100,000 women against 7.49 per 100,000 women in Germany, a difference of 1.38 per 100,000 women.
That makes Denmark's figure about 1.2 times Germany's.
Across all 15 years both countries report, Denmark has been ahead every year.
Denmark ranks 21st and Germany ranks 24th of 46 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.41 per 100,000 women | 8.54 per 100,000 women | 1.86 per 100,000 women | Denmark |
| 2010s | 10.09 per 100,000 women | 8.03 per 100,000 women | 2.06 per 100,000 women | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Denmark or Germany?
- Denmark, at 8.87 per 100,000 women against 7.49 per 100,000 women in Germany as of 2022.
- What is the difference in reported rate of new cervical cancer cases between Denmark and Germany?
- 1.38 per 100,000 women, with Denmark ahead.
- How many years of comparable data are there for Denmark and Germany?
- 15 years are reported by both, from 2003 to 2017.
- How do Denmark and Germany rank globally for reported rate of new cervical cancer cases?
- Denmark ranks 21st and Germany ranks 24th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.